Table 2.
Univariate and multivariate analyses of factors associated with CHD in NAFLD
| Non-adjusted | Model I | Model II | ||||
|---|---|---|---|---|---|---|
| OR (95%CI) | P | OR (95%CI) | P | OR (95%CI) | P | |
| BMI (kg/m2) | 1.017 (0.952–1.806) | 0.611 | ||||
| SBP (mmHg) | 1.005 (0.994–1.016) | 0.366 | ||||
| DBP (mmHg) | 1.006 (0.991–1.022) | 0.435 | ||||
| ALT (U/L) | 1.006 (0.992–1.020) | 0.395 | ||||
| AST (U/L) | 1.017 (0.994–1.042) | 0.147 | ||||
| Scr (mmol/L) | 1.017 (1.002–1.033) | 0.031 | 0.996 (0.977–1.015) | 0.681 | ||
| TC (mmol/L) | 1.090 (0.906–1.311) | 0.360 | ||||
| TG (mmol/L) | 1.452 (1.179–1.787) | < 0.001 | 1.523 (1.221–1.901) | < 0.001 | 1.453 (1.151–1.833) | 0.002 |
| HDL-C (mmol/L) | 0.217 (0.099–0.474) | < 0.001 | 0.180 (0.075–0.431) | < 0.001 | 0.221 (0.087–0.563) | 0.002 |
| LDL-C (mmol/L) | 1.657 (1.241–2.212) | 0.001 | 1.740 (1.284–2.360) | < 0.001 | 1.802 (1.305–2.489) | < 0.001 |
| FGB (mmol/L) | 1.467 (1.257–1.714) | < 0.001 | 1.447 (1.228–1.705) | < 0.001 | 1.296 (1.059–1.585) | 0.012 |
| TyG | 3.197 (2.097–4.874) | < 0.001 | 3.218 (2.075–4.992) | < 0.001 | 2.519 (1.559–4.069) | < 0.001 |
| TyG-BMI | 1.011 (1.004–1.018) | 0.001 | 1.013 (1.006–1.021) | < 0.001 | 1.009 (1.002–1.017) | 0.016 |
None, non-adjusted model. Model I was adjusted for age and sex. Model II was adjusted for age, sex, hypertension, diabetes mellitus and smoking history